Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
17.73 USD | -2.42% | +3.99% | +58.12% |
Jun. 05 | Harrow, Inc. Announces 52-Week Data from VEVYE ESSENCE-2 Open-Label Extension Study | CI |
Jun. 03 | Lake Street Raises Price Target on Harrow to $25 From $20, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+58.12% | 643M | |
+48.06% | 765B | |
-6.18% | 354B | |
+20.61% | 331B | |
+10.01% | 299B | |
+18.87% | 248B | |
-1.96% | 219B | |
+11.11% | 216B | |
+5.45% | 164B | |
-2.38% | 162B |
- Stock Market
- Equities
- HROW Stock
- News Harrow, Inc.
- B. Riley Raises Price Target on Harrow Health to $29 From $26, Keeps Buy Rating